Long Head of Biceps as an Anterior Dynamic Sling for Recurrent Anterior Shoulder Dislocation

March 6, 2025 updated by: Mohamed hussein khalil, Cairo University
Purpose: To evaluate the functional outcomes of arthroscopic onlay dynamic anterior stabilization (DAS) using the long head of biceps (LHB) tendon for treatment of anterior glenohumeral instability (AGI) with limited to subcritical glenoid bone loss (GBL).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Twenty-five patients underwent arthroscopic DAS using LHB between March 2022 and October 2022 for treatment of anterior glenohumeral instability (AGI) with limited to subcritical glenoid bone loss (GBL) were included in a prospective study with a minimum follow-up period of 2 years. The shoulder functional outcomes were assessed using the Rowe and the Quick Disabilities of Arm, Shoulder and Hand (Quick DASH) scores both preoperative and at 2 years follow-up. Magnetic resonance imaging (MRI) at 6 months after surgery to evaluate LHB tendon healing to the anterior glenoid.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Cairo
      • Giza, Cairo, Egypt
        • Faculty of medicine, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

The inclusion criteria were

  • Patients complaining of AGI, with one or more events of anterior shoulder dislocation.
  • Associated limited (<13.5%) to subcritical (<25%) GBL.
  • Positive anterior shoulder apprehension.

The exclusion criteria were

  • Associated critical GBL (≥25%).
  • Concomitant LHB lesion or rupture.
  • Multidirectional or voluntary shoulder instability.
  • Prior arthroscopic shoulder stabilization procedure.
  • Concomitant rotator cuff tears.
  • Acute proximal humerus fractures of the involved shoulder.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: arthroscopic dynamic anterior stabilization for recurrent anterior shoulder dislocation
arthroscopic dynamic anterior stabilization using Long head of biceps as for recurrent anterior shoulder dislocation arthroscopic transfer of the Long head of biceps to the anterior glenoid inpatients with recurrent shoulder dislocation
Procedure: arthroscopic dynamic anterior stabilization for recurrent anterior shoulder dislocation
arthroscopic dynamic anterior stabilization transferring long head of biceps to the anterior glenoid in patients with recurrent anterior shoulder dislocation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rowe score
Time Frame: baseline, and 2 years postoperative
shoulder score, the maximum is 100, the minimum is zero, the higher score means a better outcome
baseline, and 2 years postoperative
Quick Disabilities of Arm, Shoulder and Hand
Time Frame: baseline, and 2 years postoperative
shoulder score, the maximum is 100, the minimum is zero, the higher score means a worse outcome
baseline, and 2 years postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Investigators

  • Principal Investigator: mohamed H khalil, M.D, Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Actual)

October 31, 2024

Study Completion (Actual)

October 31, 2024

Study Registration Dates

First Submitted

March 6, 2025

First Submitted That Met QC Criteria

March 6, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 6, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • N-208-2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe